Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 26.050
- +0.350+1.36%
Trading May 8 14:12 ET
1.54BMarket Cap-20.35P/E (TTM)
26.870High24.130Low912.90KVolume25.740Open25.700Pre Close23.37MTurnover2.44%Turnover RatioLossP/E (Static)59.11MShares71.71052wk High1.51P/B974.61MFloat Cap22.52052wk Low--Dividend TTM37.41MShs Float71.710Historical High--Div YieldTTM10.66%Amplitude5.650Historical Low25.595Avg Price1Lot Size
Janux Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13.37%-43.81M | -68.92%-16.73M | 80.95%-2.23M | 33.43%-10.02M | -6.66%-14.84M | -17.83%-50.58M | 16.89%-9.9M | 12.71%-11.71M | -147.88%-15.05M | -20.73%-13.91M |
| Net income from continuing operations | -18.36%-68.99M | -71.93%-20.22M | -142.56%-28.06M | 65.96%-5.96M | 15.46%-14.76M | 7.56%-58.29M | 26.81%-11.76M | 30.71%-11.57M | -3.67%-17.51M | -30.19%-17.46M |
| Depreciation and amortization | 5.37%2.06M | -3.58%512K | 2.00%510K | 7.43%506K | 17.44%532K | 132.46%1.96M | 31.76%531K | 100.80%500K | 336.11%471K | 459.26%453K |
| Change In working capital | 110.45%685K | 68.52%-345K | 516.39%12.83M | -338.40%-7.35M | -535.29%-4.45M | -253.27%-6.55M | -231.10%-1.1M | -287.55%-3.08M | -126.36%-1.68M | 67.09%-700K |
| -Change in receivables | ---- | ---- | ---- | -1,030.80%-6.98M | 30.80%-519K | ---- | ---- | ---- | --750K | ---750K |
| -Change in prepaid assets | -1,661.90%-3.28M | -175.19%-203K | -127.17%-144K | 21.30%-1.76M | -171.01%-1.17M | 106.23%210K | 433.33%270K | 140.74%530K | -281.43%-2.24M | 217.79%1.65M |
| -Change in payables and accrued expense | 1,598.75%6.01M | -109.96%-75K | 426.78%5.75M | 86.01%2.37M | -204.20%-2.03M | -110.38%-401K | -38.68%753K | -178.07%-1.76M | 3,537.84%1.27M | -259.57%-667K |
| -Change in other current assets | 66.49%-375K | 68.72%-61K | -253.78%-183K | 85.89%-116K | 93.21%-15K | 11.89%-1.12M | 37.70%-195K | 110.42%119K | -732.31%-822K | -501.82%-221K |
| -Change in other working capital | 68.15%-1.67M | 99.69%-6K | 95.33%-92K | -34.64%-859K | -0.28%-713K | -203.78%-5.24M | -286.35%-1.92M | -1,777.14%-1.97M | -109.31%-638K | 40.75%-711K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13.37%-43.81M | -68.92%-16.73M | 80.95%-2.23M | 33.43%-10.02M | -6.66%-14.84M | -17.83%-50.58M | 16.89%-9.9M | 12.71%-11.71M | -147.88%-15.05M | -20.73%-13.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -526.36%-258.02M | 205.01%33.93M | 120.62%12.67M | -1,167.95%-190.89M | -1,201.33%-113.74M | -170.70%-41.19M | 793.45%11.12M | -410.94%-61.45M | 97.74%17.87M | -128.13%-8.74M |
| Net PPE purchase and sale | 80.59%-359K | 91.84%-42K | 94.68%-25K | 83.62%-95K | 30.88%-197K | 71.30%-1.85M | 74.95%-515K | 81.35%-470K | 35.41%-580K | 70.65%-285K |
| Net investment purchase and sale | -554.90%-257.66M | 191.87%33.97M | 120.82%12.7M | -1,133.87%-190.79M | -1,242.86%-113.54M | -160.80%-39.34M | 2,474.78%11.64M | -373.67%-60.98M | 85.71%18.45M | -126.39%-8.46M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -526.36%-258.02M | 205.01%33.93M | 120.62%12.67M | -1,167.95%-190.89M | -1,201.33%-113.74M | -170.70%-41.19M | 793.45%11.12M | -410.94%-61.45M | 97.74%17.87M | -128.13%-8.74M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,097.75%713.24M | 46,428.28%386.65M | -97.09%1.65M | 423.67%2.77M | 20,290.57%322.17M | 11,809.60%59.55M | 335.08%831K | 56.61M | 71.43%528K | 157,900.00%1.58M |
| Net common stock issuance | 1,135.21%698.27M | --378.21M | --0 | ---455K | --320.51M | --56.53M | --0 | --56.53M | --0 | --0 |
| Proceeds from stock option exercised by employees | 395.96%14.97M | 915.88%8.44M | 1,987.34%1.65M | 509.85%3.22M | 4.87%1.66M | 503.60%3.02M | 335.08%831K | --79K | 71.43%528K | 157,900.00%1.58M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,097.75%713.24M | 46,428.28%386.65M | -97.09%1.65M | 423.67%2.77M | 20,290.57%322.17M | 11,809.60%59.55M | 335.08%831K | --56.61M | 71.43%528K | 157,900.00%1.58M |
| Net cash flow | ||||||||||
| Beginning cash position | -61.68%20.02M | 53.44%27.57M | -55.16%15.48M | 585.31%213.62M | -61.68%20.02M | 43.53%52.24M | -72.60%17.97M | -41.71%34.52M | -44.28%31.17M | 43.53%52.24M |
| Current changes in cash | 1,376.81%411.4M | 19,571.26%403.85M | 173.06%12.09M | -6,018.19%-198.14M | 1,018.79%193.6M | -303.36%-32.22M | 115.41%2.05M | -360.69%-16.55M | 2.26%3.35M | -207.80%-21.07M |
| End cash Position | 2,054.84%431.42M | 2,054.84%431.42M | 53.44%27.57M | -55.16%15.48M | 585.31%213.62M | -61.68%20.02M | -61.68%20.02M | -72.60%17.97M | -41.71%34.52M | -44.28%31.17M |
| Free cash flow | 15.74%-44.17M | -60.97%-16.77M | 81.48%-2.26M | 35.29%-10.12M | -5.90%-15.03M | -6.19%-52.43M | 25.43%-10.42M | 23.57%-12.18M | -124.27%-15.63M | -13.63%-14.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
